ArticleACS omega2025
Low-Cost Label-Free Electrochemical Aptasensor for Dual Detection of Dengue and Zika Using Fluorine-Doped Tin Oxide Modified with APTES and Gold Nanoparticles.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of arbovirus infections, such as dengue and zika, has increased dramatically in recent decades, especially in tropical regions and in technologically limited places. The goal of this study is to create an affordable platform for both dengue and zika detection. Fluorine-doped tin oxide-coated substrates were modified with APTES and gold nanoparticles. The modified surfaces were functionalized with the DNA aptamer and 6-mercapto-1-hexanol. Electrochemical impedance spectroscopy was used to characterize and optimize aptasensors' performance using nonstructural protein 1 (NS1) proteins as biomarkers. The biosensor exhibited a limit of detection (LoD) of 0.21 ng/mL for dengue in phosphate-buffered saline (PBS), with a sensitivity of 19.26% per decade. In commercial human serum, the platform showed a signal increase of 2% per decade, a LoD of 0.55 ng/mL, and a sensitivity of 11.87% per decade. For zika detection, the biosensor presented 0.68 ng/mL LoD and a sensitivity of 26.34% per decade in PBS. In this case, the presence of a biological matrix from commercial human serum induced complex interaction with NS1, resulting in nonlinear sensor responses. Although this platform was not able to distinguish between zika and dengue infections, it enables the detection of both in a single test, representing a promising approach for clinical diagnostics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.